Search clinical trials for: Uroplasminogen Plasminogen Activator Receptor

Total 18536 results

Rigshospitalet, Denmark

Unknown

uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer

Neoplasms | Neoplasms by Site | Head and Neck Neoplasms | Oral Cancer | Oropharyngeal Cancer | Cancer of Mouth

Denmark
Rigshospitalet, Denmark

Completed

Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

Breast Cancer | Prostate Cancer | Urinary Bladder Cancer

Denmark
Karamanoğlu Mehmetbey University

Not yet recruiting

Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease

Periodontitis | Periodontal Diseases
The University of Texas Health Science Center,...
Baszucki Brain Research Fund

Recruiting

A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression

Bipolar Depression

United States
ASST Fatebenefratelli Sacco
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Careggi Hospital; University Hospital Tuebingen and other collaborators

Not yet recruiting

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels (PERIPLO)

Pericarditis

Germany, Italy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke (AGREE)

Ischemic Stroke

China
Larissa University Hospital

Recruiting

The Role of Ischemia Modified Albumin in Patients With COVID-19

COVID-19

Greece
Yonsei University

Recruiting

Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart Disease

Severe Aortic Stenosis or Severe Aortic Regurgitation

Korea, Republic of
Assiut University

Not yet recruiting

Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .

Behçet Disease
Iuliu Hatieganu University of Medicine and Pharmacy

Completed

Interventions Meant to Improve the Outcome of Critical Care Patients in the ED

Sepsis Syndrome | Emergency Department | Biomarker

Romania
University of Southern Denmark

Completed

Diagnostic Accuracy of Infection Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia

Pneumonia, Bacterial

Denmark
University of Southern Denmark

Completed

Accuracy of Infection Biomarkers in the Investigation of Patients With Suspected Acute Pyelonephritis

Acute Pyelonephritis

Denmark
General Hospital of Shenyang Military Region

Completed

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke (ARAMIS)

Stroke

China
Rigshospitalet, Denmark

Completed

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Neuroendocrine Tumors

Denmark
University of Thessaly

Completed

SuPAR in Adult Patients With Covid-19 (SPARCOL)

Covid19

Greece
The George Institute
National Health and Medical Research Council, Australia; Takeda; Conselho Nacional... and other collaborators

Completed

Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) (ENCHANTED)

Ischemic Stroke | High Blood Pressure

Australia
Michael Patrick Achiam

Completed

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer

Esophagus Cancer, Adenocarcinoma

Denmark
Karolinska Institutet

Completed

Prehospital Recognition and Identification of Unspecific Symptoms (PRIUS)

Morality | Serious Condition

Finland, Sweden
University of Thessaly

Completed

Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac Surgery (SPARSE) (SPARSE)

Surgery--Complications

Greece
Cengiz Gokcek Women's and Children's Hospital

Unknown

Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM (melatonin&PROM)

Preterm Premature Rupture of Membranes

Turkey
Georgetown University

Unknown

A Crossover Pilot Study of the Effect of Amiloride on Proteinuria

Proteinuria

United States
Vanderbilt University Medical Center
National Center for Research Resources (NCRR)

Completed

Diurnal Variation of Plasminogen Activator Inhibitor-1

Metabolic Syndrome X

United States
Rigshospitalet, Denmark

Unknown

uPAR-PET/MRI in Glioblastoma Multiforme

Glioblastoma Multiforme

Denmark
Kristoffer Staal Rohrberg
Janssen-Cilag Ltd.

Terminated

Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer (uPARCRPC)

Prostatic Neoplasms

Denmark
Rabin Medical Center

Unknown

Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke

Ischemic Stroke

Israel
Ankara University

Unknown

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal Sepsis (suPAR)

Neonatal Sepsis

Turkey
The First Hospital of Jilin University

Not yet recruiting

The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced Coagulopathy

Sepsis-induced Coagulopathy
Kafrelsheikh University

Recruiting

Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction

Ischemic Stroke | Alteplase Adverse Reaction

Egypt
Second Affiliated Hospital of Nanchang University
Changhai Hospital

Recruiting

Early Lumbar Drainage Combined With Intrathecal Urokinase Injection for Treatment of Severe Aneurysmal SAH (LD-ITUK)

Aneurysmal Subarachnoid Hemorrhage

China
The Second Hospital of Hebei Medical University

Recruiting

Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol (TASPE)

Acute Ischemic Stroke

China
Chinese University of Hong Kong
Queen Mary Hospital, Hong Kong; Princess Margaret Hospital, Canada; Tuen Mun... and other collaborators

Not yet recruiting

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC (DOAC-IVT)

CVA (Cerebrovascular Accident)

Hong Kong
Beijing Tiantan Hospital

Recruiting

Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5 (TRACE-5)

Ischemic Stroke, Acute

China
The First Affiliated Hospital of Zhengzhou University
Techpool Bio-Pharma Co., Ltd.

Recruiting

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

Acute Ischemic Stroke

China
Kristina Svennerholm
Karolinska University Hospital; Sunderby Hospital; University Hospital, Linkoeping and other collaborators

Recruiting

Mechanical Thrombectomy With the FlowTriever Device in Acute Pulmonary Embolism - a Retrospective Analysis

Pulmonary Embolism

Sweden
Second Affiliated Hospital, School of Medicine,...

Recruiting

ALteplase in Patients With LOW NIHSS and Specified Disabling Deficits (ALLOW)

Thrombosis

China
Huashan Hospital
Shanghai 10th People's Hospital; Shanghai Fifth People's Hospital; Shanghai Deji... and other collaborators

Recruiting

Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China (TTT-AIS CHINA)

Ischemic Stroke

China
Shionogi

Recruiting

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke (REvive)

Acute Ischemic Stroke

Japan, Israel, United States, Australia, Hong Kong
National University of Malaysia

Recruiting

Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic (PENTAD-FT)

Pleural Infection

Malaysia
Xuanwu Hospital, Beijing

Recruiting

Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation (IAT-TOP)

Acute Ischemic Stroke | Arterial Thrombosis | Posterior Circulation Brain Infarction

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shenzhen Hospital of Southern Medical University

Recruiting

Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL)

Stroke, Acute Ischemic

China
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; University of Cambridge; University of Newcastle Upon-Tyne and other collaborators

Recruiting

Pulmonary Hypertension: Intensification and Personalisation of Combination Rx (PHoenix)

Pulmonary Arterial Hypertension

United Kingdom
Hospital Clinic of Barcelona
Fundacion Clinic per a la Recerca Biomédica; Instituto de Salud Carlos III

Not yet recruiting

CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2). (CHOICE2)

Stroke, Acute | Stroke, Acute Ischemic

Spain
Chinese University of Hong Kong

Not yet recruiting

Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)

Pleural Infection

Hong Kong
Beijing Tiantan Hospital
Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd; The Place Pharmaceutical(Jiangsu)...

Recruiting

Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Acute Ischemic Stroke

China
Tianjin Huanhu Hospital

Recruiting

MR Imaging Selection for Endovascular Treatment in Acute Ischemic Stroke at 6 to 24 Hours (MIELS)

Endovascular Thrombectomy

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Application of tPA in Suprachoroidal and Subretinal Hemorrhage

Ocular Trauma

China
Xinqiao Hospital of Chongqing
Zhejiang University

Recruiting

Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke (ADJUVANT)

Stroke, Acute Ischemic

China
Centre Hospitalier Sud Francilien

Recruiting

Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes (DISTAL-IVT)

Acute Distal Vessel Occlusion Stroke

France
Sichuan Academy of Medical Sciences
Sichuan Provincial People's Hospital

Recruiting

Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke (BEST-BAO)

Thrombosis | Acute Ischemic Stroke | Basilar Artery Occlusion | Endovascular Treatment | Alteplase

China
Beijing Tiantan Hospital

Recruiting

Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization (ANGEL-TNK)

Ischemic Stroke, Acute

China

Search clinical trials for: Uroplasminogen Plasminogen Activator Receptor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations